Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
- 21 May 2012
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 57 (3), 564-571
- https://doi.org/10.1016/j.jhep.2012.04.022
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Peginterferon alfa‐2a for hepatitis C after liver transplantationHepatology, 2005
- One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infectionLiver Transplantation, 2004
- Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combinationJournal of Hepatology, 2004
- Pegylated interferon α‐2b plus ribavirin in the treatment of post‐liver transplant recurrent hepatitis CClinical Transplantation, 2004
- Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-upTransplantation, 2004
- Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized studyGastroenterology, 2003
- Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipientsHepatology, 2002
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- European collaborative study on factors influencing outcome after liver transplantation for hepatitis CGastroenterology, 1999
- A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantationHepatology, 1998